Showing 13 to 15 of 15 results


Oz to Divest Stock Before Potentially Leading CMS
Dr. Mehmet Oz, nominated to lead the Centers for Medicare & Medicaid Services, plans to divest millions of dollars in healthcare stock and sever ties with several companies to avoid conflicts of interest, but questions remain about his ongoing media presence and complete divestment from iHerb.
Oz to Divest Stock Before Potentially Leading CMS
Dr. Mehmet Oz, nominated to lead the Centers for Medicare & Medicaid Services, plans to divest millions of dollars in healthcare stock and sever ties with several companies to avoid conflicts of interest, but questions remain about his ongoing media presence and complete divestment from iHerb.
Progress
48% Bias Score


First U.S. Avian Flu Death Prompts Emergency Response and Increased Preparedness
Louisiana reported the first U.S. death from avian flu, a man over 65 who contracted the H5N1 virus after contact with dead birds; this prompted a California state of emergency declaration despite assurances of low population risk, but the situation highlights the need for increased preparedness mea...
First U.S. Avian Flu Death Prompts Emergency Response and Increased Preparedness
Louisiana reported the first U.S. death from avian flu, a man over 65 who contracted the H5N1 virus after contact with dead birds; this prompted a California state of emergency declaration despite assurances of low population risk, but the situation highlights the need for increased preparedness mea...
Progress
40% Bias Score

Trump's Healthcare Policies Spark Controversy and Uncertainty
President Trump announced the US withdrawal from the World Health Organization on his first day in office, prompting criticism from public health experts and raising concerns about the US's role in global health initiatives; other executive orders impact drug pricing and public health data releases.

Trump's Healthcare Policies Spark Controversy and Uncertainty
President Trump announced the US withdrawal from the World Health Organization on his first day in office, prompting criticism from public health experts and raising concerns about the US's role in global health initiatives; other executive orders impact drug pricing and public health data releases.
Progress
40% Bias Score
Showing 13 to 15 of 15 results